IndraLab

Statements

PSMD14 activates 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide. 1 / 1

| 1

reach

"To verify the effects of both PSMD11 and PSMD14 in pancreatic cancer, we confirmed that the knockdown of PSMD11 and PSMD14 could inhibit the malignant biological behaviors of pancreatic cancer cells, such as their proliferation, migration, and invasion, via the MTT assay, cell scratch assay, and transwell assay, which suggested that these two proteins could be used as potential markers for pancreatic cancer progression and prognostic assessment."

40182048

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

PSMD14 activates 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide. 1 / 1

INDRA sources:

Databases

Reading